Crossmark

EGFR is required for FOS‐dependent bone tumor development via RSK2/CREB signaling

Crossref DOI link: https://doi.org/10.15252/emmm.201809408

Published Online: 2018-10-25

Published Print: 2018-11

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Linder, Markus

Glitzner, Elisabeth

Srivatsa, Sriram

Bakiri, Latifa

Matsuoka, Kazuhiko

Shahrouzi, Parastoo

Dumanic, Monika

Novoszel, Philipp

Mohr, Thomas

Langer, Oliver

Wanek, Thomas

Mitterhauser, Markus

Wagner, Erwin F

Sibilia, Maria https://orcid.org/0000-0001-6129-5613
Funding

Funding for this research was provided by:

Austrian Science Fund (DK W1212)

Austrian Science Fund (SFB F35)

H2020 European Research Council (ERC‐2015‐AdG TNT‐Tumors 694883)
License Information

Version of Record valid from 2018-10-25
More Information

Publication History

Received: 2018-06-08

Accepted: 2018-09-25

Published: 2018-10-25